2019 Conference on Retroviruses and Opportunistic Infections*

Retroviruses 2019 Program Image
March 4-7, 2019; Seattle, Washington
Get up to date on the latest HIV data with rapid Capsule Summaries, downloadable slidesets, and expert analysis covering key studies from Seattle.
W. David Hardy, MD
Daniel R. Kuritzkes, MD
Karine Lacombe, MD, PhD
person default
Esteban Martínez, MD, PhD
person default
Cristina Mussini, MD
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
Jürgen K. Rockstroh, MD
David A. Wohl, MD

Highlights From CROI

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty reviewed the most clinically relevant new HIV data presented at CROI 2019 and answered questions from participants.

David A. Wohl, MD Released: April 1, 2019

Here’s my summary of interesting new data to look forward to from CROI 2019.

David A. Wohl, MD Released: March 1, 2019

Among the most noteworthy data presented at CROI 2019 were results from the phase III ATLAS and FLAIR studies of long-acting injectable cabotegravir plus rilpivirine. Here’s my take on how this regimen, if approved, could benefit people living with HIV.

W. David Hardy, MD Released: May 10, 2019

In this downloadable slideset, expert faculty members summarize key studies from this important annual conference.

Released: March 22, 2019

This expert-led CME/CE-certified Conference Coverage provides a comprehensive review of key data on the prevention and management of HIV infection from the 2019 Conference on Retroviruses and Opportunistic Infections.

W. David Hardy, MD Daniel R. Kuritzkes, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 13, 2019 Expiration: June 12, 2020

European Perspectives

New data show an association between weight gain and specific ART regimens that are commonly recommended in expert guidelines. How do these data fit with current weight gain trends, and what do they mean for the general health of patients in Spain?

person default Esteban Martínez, MD, PhD Released: May 2, 2019

New data on FTC/TAF demonstrate noninferior HIV prevention efficacy vs FTC/TDF as daily oral PrEP among cis-MSM and transgender women. What do these results mean in the context of new German legislation around reimbursement for PrEP?

Jürgen K. Rockstroh, MD Released: April 5, 2019

Treatment of acute hepatitis C infection presents a clinical challenge for the elimination of HCV, particularly in patients with HIV infection and pregnant women. New CROI 2019 data begin to address these challenges.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: May 9, 2019

New data reported at CROI 2019 demonstrate improved virologic outcomes and comparable safety with RAL or DTG vs EFV initiated during the second or third trimesters of pregnancy. What do these results mean for HIV care providers treating woman during pregnancy in France?

Karine Lacombe, MD, PhD Released: July 18, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty reviews the most clinically relevant new HIV data presented at CROI 2019, with an emphasis on findings of interest to European treatment providers.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: April 1, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty reviewed the most clinically relevant new HIV data presented at CROI 2019 and answered questions from participants.

person default Esteban Martínez, MD, PhD Released: May 1, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty reviewed the most clinically relevant new HIV data presented at CROI 2019 and answered questions from participants.

person default Cristina Mussini, MD Released: May 1, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty reviewed the most clinically relevant new HIV data presented at CROI 2019 and answered questions from participants.

Jürgen K. Rockstroh, MD Released: May 1, 2019
Directly provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This program is supported by independent educational grants from
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?